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Answer to comments of Reviewer 1: 
 
1. There are a number of abbreviations used in the text which it would be helpful to add to the 
Abbreviations list at the beginning of the document (e.g. M1dG, M1dA, AcrdG, CrodG, BER, 
NER, MDA, HNA, DHN, NSCLC). 
We included suggested abbreviations as well as added several new to the List of 
Abbreviations.  
2. Page 4, 3rd line of text. There should, presumably be a closing ) and full stop after 
“[formula 1]”.  
Corrected. 
3. Page 4: it should perhaps be also noted that lipid hydroperoxides can be directly reduced, 
in a two-electron process, to the corresponding alcohols by species such as glutathione 
peroxidase-4. 
We included this suggestion into the final text on p. 5. bottom. 
4. Page 4, second paragraph. The second and third lines may be clearer if reworded as 
follows ….”undergoes cyclization to a cyclised peroxyl radical …. [formula 5], which can 
undergo further reactions to form unstable peroxides and a series of unstable oxidised fatty 
acid products (Fig. 1. [formula 6 and 7]) 
We simplified this paragraph according to the suggestion of the reviewer. 
5. Page 4, second paragraph, last line: converts the lipid peroxyl radicals into a relatively 
stable lipid hydroperoxides [7,10].  
 
Corrected 
 
6. Page 5, section 3: it would be very helpful for the reader if data on the approximate levels 
of HNE, peroxides and related species were given. This is of critical importance in evaluating 
cell studies where these materials are added in, often at huge levels that are clearly not 
pathologically relevant. It is important that new workers in the field, do not succumb to using 
levels that are clearly inappropriate. 
 
On p. 6 we added a paragraph about the levels of lipid hydroperoxides and TBARS in human 
blood plasma and lymphocytes. 
7. Page 6. This reviewer is not a fan of single sentence paragraphs. To my mind it would be 
better if the various small paragraphs written here were linked together in a single 
paragraph.  
We linked together small paragraphs previously slightly changing composition of this part of 
the final text. 
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8. Page 7, line 7 of section 4: export of this complex from the cell…   
Corrected 
 
9. Page 10, penultimate line: the sentence “It is suggested that they derive from HNE…” 
needs a reference. 
 
Reference added. 
10. Page 14, section 8: as above, some absolute estimates as to the levels / abundance of 
these materials in pathological specimens would be very helpful and useful (fold increases are 
interesting – as given in Table 1, but the absolute values are more valuable and useful). 
Absolute values of ethenoadducts levels found in pathological specimens were included as a 
new column to the Table 1. 
11. The reference section needs to be re-formatted in the style of the journal (e.g. list all 
authors, text not in bold, etc. 
The reference section was reformatted. 
 
Answer to comments of Reviewer 2: 
 
1. The authors mostly presented about HNE and MDA, even though the title is “ Lipid 
peroxidation ---”. There are a lot of lipid peroxides, and each one gives different adduct. It 
may be better to improve the title.   
 
We agree that there are plethora of LPO products, and we were unable to describe all of them. 
However, the consequences of the major LPO products were described. That is why we 
changes the title to the following: 
"Damage of DNA and proteins by major lipid peroxidation products in genome stability" 
 
2. Keywords in the first page are not same as in the title page. 
Corrected 
 
3. Figure 6: The legend should be “ by malondialdehyde products” but not “by LPO 
products”. 
Legend was changed to  “The major exocyclic DNA adducts” 
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ethenoadenine; εC, 3,N4-ethenocytosine; 1,N2-εG, 1,N2-ethenoguanine; N2,3εG, N2,3-
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group; HNA, 4-hydroxy-2-nonenoic acid; HNE, trans-4-hydroxy-2-nonenal; LPO, lipid 
peroxidation; M1dA, N6-(3-oxopropenyl)-2'-deoxyadenosine; M1dG, pirymido-[1,2α]purine-
10(3H)-one-2'-deoxyribose; MDA, malondialdehyde; Me-methyl group; NER, Nucleotide 
Excision Repair; NSCLC, non-small cell lung cancer 
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 3 
Abstract 
Oxidative stress and lipid peroxidation (LPO) accompanying infections and chronic 
inflammation may induce several human cancers. LPO products are characterized by 
carbohydrate chains of different length, reactive aldehyde groups and double bonds, which 
make these molecules reactive to nucleic acids, proteins and cellular thiols. LPO-derived 
adducts to DNA bases form etheno-type and propano-type exocyclic rings, which have 
profound mutagenic potential, and are elevated in several cancer-prone diseases. Adducts of 
long chain LPO products to DNA bases inhibits transcription. Elimination from DNA of 
LPO-induced lesions is executed by several repair systems: base excision repair (BER), direct 
reversal by AlkB family proteins, nucleotide excision repair (NER) and recombination. 
Modifications of proteins with LPO products may regulate cellular processes like apoptosis, 
cell signaling and senescence. This review summarizes consequences of LPO products 
presence in cell, particularly 4-hydroxy-2-nonenal in terms of genomic stability. 
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 4 
1. Introduction 
 Living organisms undergo permanent exposition to damaging agents which may arise 
from environmental and endogenous processes. Damaging agents react with all cellular 
components, including proteins, lipids and nucleic acids. It has been estimated that every day 
approximately 20 000 DNA lesions originating from endogenous sources are formed in every 
cell of the human organism. Several mechanisms participate in the generation of DNA 
modifications, namely deamination, spontaneous hydrolysis of the N-glycosidic bond, 
alkylation and activity of free radicals, which include reactive oxygen (ROS) and nitrogen 
species (RNS), and lipid peroxidation (LPO) products [1-3]. However, ROS, RNS and, LPO 
products play a dual role in cells. At low or moderate concentrations they are mediators of 
specific physiological processes. High concentrations can be detrimental to all components of 
the cell. Overproduction of oxygen species combined with insufficiency in protective 
mechanisms of anti-oxidative defense is defined as oxidative stress [4, 5]. 
DNA damage caused by free radicals is probably the most heterogeneous group of DNA 
lesions due to the wide variety of deleterious molecules produced in cells in the conditions of 
oxidative stress. Free radicals can be generated by irradiation (X rays, γ-rays, UV light), drugs 
or heat; however, most of them are formed in normal metabolic processes that occur in every 
cell [4-6]. 
 This paper will focus on lipid peroxidation, interaction of LPO products with DNA 
and proteins and biological consequences of these processes. 
 
2.  Lipid Peroxidation 
A growing body of evidence suggests that many of the detrimental cellular effects 
observed under oxidative stress conditions are mediated by the products of lipid degradation 
[7]. Particularly susceptible to peroxidation are polyunsaturated fatty acids (PUFA) as they 
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 5 
possess a number of double bonds. Lipid peroxidation occurs in three phases, initiation, 
propagation and termination [8]. In the initiation phase an oxidant abstracts a hydrogen atom 
from a C-H bond of lipid to generate carbon-centered lipid radical (Fig.1 [formula 1]). In the 
propagation phase carbon-centered radical reacts with O2 to form peroxyl radical (Fig. 1 
[formula 3]). Peroxyl radical may further react with another molecule of PUFA and abstract a 
hydrogen atom from the fatty acid chain. This feature leads to propagation of the chain 
reaction of lipid peroxidation. As a result, a single initiation reaction can generate hundreds of  
lipid peroxides of different structures. For example, if the peroxyl radical exists at one of the 
two ends of the double-bond (Fig. 1 [formula 2]), it is reduced to hydroperoxide (Fig. 1 
[formula 4]). Conjugated diene hydroperoxides (Fig. 1 [formula 4]) are stable in the absence 
of metals. Metal complexes and metalloproteins abundant in cells can reduce all fatty acid 
hydroperoxides to alkoxyl radicals, which subsequently undergo multiple chemical reactions 
to generate broad range of products, depending on the chemical structure of the precursor 
lipid [9]. 
If the peroxyl radical is at the internal position in the fatty acid chain (Fig. 1 [formula 
3]) it undergoes cyclization to a cyclised peroxyl radical (Fig. 1 [formula 5]), which can 
undergo further reactions to form a series of unstable oxidized fatty acids (Fig. 1 [formula 6 
and 7]). These fatty acids give rise to final products, like isoprostanes and malondialdehyde 
(MDA) [9]. LPO is terminated when the chain reaction is interrupted by a reaction of lipid 
radical with another lipid radical or lipid peroxide with a molecule of antioxidant, which 
provides the hydrogen atom that converts the lipid peroxyl radicals into a relatively stable 
lipid hydroperoxides [7, 10].  
Lipid hydroperoxides may undergo further reactions and rearrangements. They can be 
directly reduced to the corresponding alcohols by e.g. glutathione peroxidase GPx4, which 
was reported as a major cellular enzyme dedicated for lipid hydroperoxides scavenging [11, 
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 6 
12]. Alternalively, lipid hydroperxides give rise to several other groups of molecules that 
include smaller derivatives of the original molecule. These short chain reactive aldehydes are 
relatively stable and can diffuse throughout the whole cell attacking other biomolecules. Short 
chain reactive aldehydes are classified into the following families: 2-alkenals (e.g. acrolein, 
crotonaldehyde, 2-hexenal), 4-hydroxy-2-alkenals (e.g. 4-hydroxy-2-hexenal - HHE, 4-
hydroxy-2-nonenal - HNE) and ketoaldehydes  (e.g. malondialdehyde - MDA, glyoxal, 4-oxo-
2-nonenal - ONE) [7] (Fig. 2). Multiplicity of LPO products is tremendously augmented by 
the existence of  stereoisomers of several of these compounds.  
 Concentrations of reactive aldehydes usually vary depending on the tissue analysed, 
health status and age of examined organism. In solid tissues the level is usually an order of 
magnitude or more higher than in blood plasma [20]. In blood serum of breast cancer women 
the level of plasma lipid hydroperoxides (LH) ranged from 0.12 to 1.85 µM whereas plasma 
TBARS (Thiobarbituric Acid Reactive Substances, well-established method for monitoring 
lipid peroxidation) ranged from 3.09 to 6.84 µM [13]. TBARS in healthy children ranged 
from 1.22 to 1.36 µM [14] whereas in another study TBARS in healthy male subjects ranged 
from 0.5 to 2.2 µM (average 1.2 ± 0.3 µM) in sera whereas average level of lipid 
hydroperoxides was 3.9 ± 1.5 µM (range 1.9- 6.9) in sera [15]. The other study determined the 
levels of MDA in lymphocytes obtained from healthy subjects grouped according to the age. 
The average MDA level was 12.35 ± 0.37 nmol/mg protein in the group of young persons 
(11-20 years old) and increased with age reaching the highest average value of 33.63 ± 0.42 
nmol/mg protein in the group of elderly persons (51-60 years) [16].  
 
 
 
 
 
3.  HNE as a prevalent LPO product and its reactivity 
     Among numerous products of lipid peroxidation two major and most extensively 
studied are malondialdehyde (MDA) and 4-hydroxy-2-nonenal (HNE). One of the possible 
Page 9 of 58
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
 
 7 
pathways of MDA formation is presented in Fig. 1. The best known consequences of MDA 
presence in cells are MDA interactions with nucleic acids and induction of mutations 
(described below). However, best described in respect of protein modification, changing gene 
transcription, and cell signaling is HNE. Although probably all LPO products interact with 
proteins and may affect cell metabolism, knowledge of the resulting consequences is mostly 
based on reactions of HNE.  
HNE is generated from ω6 PUFA, mainly during non-enzymatic peroxidation of 
linoleic acid and arachidonic acid. In a study using 9 and 13 hydroperoxides of linoleic acid 
(13-hydroxyperoxy-octadecenoic acid (13(S)-HPODE) and 9-hydroxyperoxy-octadecenoic 
acid (9(R)-HPODE)) as initial material, it was shown that two distinct mechanisms may lead 
to the formation of HNE. Hydrogen abstraction from C8 of 13(S)-HPODE and subsequent 
cleavage of the resulting 10, 13-dihydroperoxide between C9 and C10 gives 4(S)-HPNE (4-
hydroperoxy-2-nonenal). Cleavage of 9(R)-HPODE forms 3Z-nonenal, which is a precursor 
of 4(R,S)-HPNE. Subsequent simple reduction step of 4-HPNE leads to HNE formation (Fig. 
3) [7, 17]. 
Apart from uncontrolled radical-derived pathway of HNE formation, a certain amount 
of this compound may be generated via enzymatic reactions. Two most important enzymes 
are lipooxygenases (LOX) and cyclooxygenases (COX), which oxidize arachidonic acid to 
form mediators of inflammation, prostaglandins, prostacyclins or leukotrienes. The finding 
that 15LOX isoform oxidizes linoleates exclusively to 13(S)-HPODE, a precursor for HNE, 
has led to inclusion of these enzymes in the group of potential factors enhancing LPO [18, 
19].  
HNE is an amphiphilic compound with three functional chemical groups, which 
determine its reactivity. Interplay of the double CC bond, carbonyl group (CO) and hydroxyl 
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 8 
group (OH) provides partially positive charge at carbon 3 and carbon 1, which are the sites of 
nucleophilic attack by other compounds (e.g., thiols or amino groups). 
HNE can be involved in two types of chemical reactions. It may undergo Michael 
addition reaction with biomolecules containing amino and/or thiol groups like cysteine, 
lysine, the imidazole group of histidine or glutathione (Fig. 4), as well as it can form Schiff-
base with primary amines (e.g., lysine) (Fig 5) [10]. The latter reaction is competitive with 
Michael addition. Nevertheless, within cells, HNE may contribute to cross-linking of proteins. 
The reaction of Schiff base formation between HNE and lysine of a particular protein 
followed by the second reaction of Michael addition with a lysine of another protein results in 
binding of two proteins [10]. Reactivity of HNE with proteins and nucleic acids, which are the 
primary targets for HNE, determines its biological effects in cell. HNE forms adducts to side 
chains of Cys, His and Lys in proteins. Among them the most reactive with HNE is Cys, 
which undergoes HNE addition two and three orders of magnitude more efficiently than His 
and Lys, respectively [20].  However,  the exact site of modification of proteins by HNE is 
determined not only by the reactivity, but also by additional factors like polarity of 
microenvironment, tertiary structure of protein or accessibility of the side chain to HNE. 
There is a plethora of data documenting protein modification by HNE in vitro and in vivo. 
HNE targets a variety of oxidoreductases, transferases, hydrolases, lyases, kinases, ion 
channels and many other proteins. In general, HNE adducts to proteins diminish their activity, 
although some examples of activation are also known [20]. 
 
4. Biological effect of HNE 
Intracellular concentration of HNE may range from submicromolar, usually 0.1-3 µM,  
in blood plasma under physiological conditions, up to 5 mM under conditions of oxidative 
stress in cellular compartments adjacent to membranes. Concentration of HNE in cell is 
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 9 
mostly regulated by a coordinated function of glutathione-S-transferases (mainly by GSTA4-4 
and hGST5.8 isoforms) and the RLIP76 transporter. Glutathione-S-transferases (GSTs) 
catalyze conjugation of HNE to glutathione (GSH), whereas RLIP76 is engaged in ATP-
dependent export of this complex from the cell [21]. HNE-GSH transfer is the most rapid and 
effective way of HNE neutralization, but HNE can also be metabolized by aldehyde 
dehydrogenase to corresponding carboxylic acid –  HNA (4-hydroxy-2-nonenoic acid), and 
alcohol dehydrogenase to corresponding alcohol – DHN (1,4-dihydroxy-2-nonene) [22]. The 
proportion between these three metabolites in rat hepatocytes was 6:4:1 for HNE-GSH: HNA: 
DHN respectively [23].  
Although cells are equipped with tools that prevent uncontrolled action of HNE, under 
conditions of oxidative stress defense mechanisms seem to be insufficient to maintain cellular 
homeostasis. HNE was shown to be a ubiquitous molecule that could very easily diffuse along 
all cellular compartments in a much more effective way than “oxygen mediators”, like 
hydrogen peroxide that acted mainly in the cytosol [24]. HNE at 0.1-10 µM, close to 
physiological concentrations in blood plasma, stimulates cellular proliferation, reduces 
differentiation and activates cytoprotective response. It activates JNK and p38 kinases which 
are known to act in response to cellular stresses and are members of the MAPK family that 
transduces signals through phosphorylation cascades [25, 26]. It also activates tyrosine kinase 
receptors (RTKs), such as EGF and PDGF receptors [27, 28] and protein kinase C [29].  At 
high concentrations, HNE is cytotoxic and shows its detrimental potential to cellular 
compounds. Proteins are the primary targets for HNE, as it was reported that adducted 
proteins are the second most abundant group of HNE-derivatives, just after HNE-GSH, HNA 
and DHN metabolites. Proteins moderately modified with HNE are degraded in the 
proteasome, whereas extensive modification leading to protein cross-links may result in the 
formation of large aggregates that inhibit proteasome [30]. On the other hand, HNE may also 
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 10
directly inhibit proteasome, however, such effect was observed only at very high (1 mM and 
higher) HNE concentrations [31]. High HNE concentrations also influence signaling 
pathways, but usually the effects of its activity are different from those observed at 
physiological doses. For example,  at high concentrations HNE induces apoptosis through the 
death receptor Fas, TP53 and liberation of cytochrome c from mitochondrial membranes [32]. 
Generally, HNE introduced into eukaryotic cells exhibits pleiotropic effects depending on the 
concentration and the cell type. 
HNE also alters gene expression. In microarray experiments RKO cells treated with 
HNE responded by induction or downregulation of hundreds of genes. Among them, genes 
responsible for antioxidant response, heat shock and ER stress displayed the most significant 
changes in the quantity of transcripts. Nevertheless, transcription of genes whose products are 
engaged in many other processes, like cell signaling, apoptosis, cell cycle regulation or 
transcription regulation, was also influenced by HNE. This demonstrates that HNE 
simultaneously affects multiple cellular pathways, which in consequence gives rise to a 
complex response of the cell [32-34]. 
 
5. Modification of DNA bases by LPO products and their processing by DNA 
polymerases 
Directly oxidized DNA bases, for years were considered major, harmful DNA lesions.  
It is now clear that modifications generated by LPO products may contribute to DNA damage 
to nearly the same extent as directly oxidized bases. There are distinct groups of linear and  
cyclic LPO specific DNA lesions. 
Malondialdehyde reacts in DNA with guanine, adenine and cytosine to form cyclic 
pirymido-[1,2α]purine-10(3H)-one-2'-deoxyribose (M1dG) adduct and linear N6-(3-
oxopropenyl)-2'-deoxyadenosine (M1dA) and N4-(3-oxopropenyl)-2'-deoxycytosine (M1dC) 
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 11
adducts, respectively [9]. M1dG (Fig. 6) is the major MDA-DNA adduct and was detected in 
human and rodent tissues. In E. coli cells, it induces transversions to T and transitions to A 
with a frequency comparable with that of 8-oxoG [4]. 
Exocyclic propano DNA adducts are formed by the attachment of LPO product that generates 
additional saturated, six-membered ring in a DNA base. These adducts are derived from the 
reaction of DNA with acrolein, crotonaldehyde and HNE. Acr-dG, Cro-dG and HNE-dG were 
found in rodent and human tissues [35, 36]. 
 Etheno DNA adducts (Fig. 6) posses five-membered exocyclic rings attached to DNA 
bases. The exact pathway of their formation in vivo is not known, although it is clear that they 
may be generated in vitro by the exposition of DNA to lipid peroxides. Ethenoadducts are 
also introduced into DNA by certain environmental carcinogens like vinyl chloride or its 
metabolite, chloroacetaldehyde (CAA) [37].  
Propano- and etheno-type adducts that are found in native mammalian DNA are 
unsubstituted and substituted with side chains of different length, depending on the structure 
of reacting LPO product. For example, HNE may d rectly interact with guanosine, adenosine, 
cytidine and thymidine moiety in DNA. Michael addition, followed by Schiff base formation 
by HNE aldehyde group leads to formation of 1N2-propanodeoxygunosine (Fig. 7) and 
plethora of HNE adducts to C, A and T. Thymine adducts are linear, due to the fact that 
thymine is deprived of exocyclic amino group. HNE and other LPO adducts to G, C and A are 
cyclic in nucleosides, nucleotides and single-stranded DNA. In double stranded DNA the 
reaction of aldehyde group is reversible. This results in the appearance of linear adducts, 
which are flexible and may be tolerated to some degree by DNA polymerases [38], on one 
hand, and on the other may form new Schiff base linkage with the amino- groups of nucleic 
acids and amino acids to create inter- and intra-strand DNA-DNA cross-links and DNA-
protein crosslinks. In the presence of oxygen HNE unergoes epoxidation and reacts with G, C 
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 12
or A moieties in DNA that leads to ethenoadducts formation, substituted with heptyl side 
chains [10, 39] (Fig. 8).  
 In vitro reaction of HNE with DNA bases is of different efficiency. dG and dC are 
primary targets, while dA reacts with much lower efficiency, and HNE adducts to dT are in 
minority [39]. Etheno-type adduct of HNE to guanosine, 1,N2ε-guanosine, and propano-type 
cyclic 1,N2-propanodeoxyguanine were shown to occur as four diastereoisomers of tetracyclic 
structure (purine condensed with ethano and furano rings) [40, 41]. These isomers were shown 
to have different mutagenic potency [42]. Other cyclic DNA adducts deriving from acrolein 
and crotonaldehyde occur in stereomeric forms as well [43, 44]. 
 There is a lot of controversies concerning formation of unsubstituted etheno-DNA 
adducts. It is suggested that they derive from HNE [45, 46]. In oxidizing conditions HNE may 
form small amounts of unsubstituted etheno-DNA adducts, however the available data from 
in vitro studies are not consistent. Chen and Chung [45] demonstrated that under oxidizing 
conditions the ratio of unsubstituted to substituted ethenoadenine is 6:100, of unsubstituted to 
substituted guanine equals 24:100, and the number of unsubstituted ethenoadducts is 
significantly decreased under nitrogen. However, our previous in vitro studies showed that in 
oxidizing conditions only guanosine yielded unsubstituted 1,N2-εdG, and only in the amount 
of 1-2 % of modified dG [39]. Unsubstituted ethenoadducts are formed from unsaturated fatty 
acids in animals and humans [47], however the exact pathway of their formation is not clear. 
One suggested possibility of 1,N2-εdG formation is from HNE precursor, 4-hydroperoxy-2-
nonenal (HPNE) [48]. 
 
6. Sequence-specificity in the formation of exocyclic-DNA adducts and repair kinetics  
 Specific sequences in DNA, which favour formation of tertiary structures containing 
single-stranded fragments, e.g. palindromic loops, cruciforms and GC-rich sequences may be 
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 13
particularly susceptible to formation of exocyclic DNA adducts. Studies of Chung and 
coworkers [49] have shown that in human cells HNEdG adducts were formed preferentially in 
the third guanine residue of the codon 249 of TP53 gene. This site was found to be a 
mutational hot-spot in numerous types of human cancers [50], which shows that tertiary DNA 
structure is of importance in the induction of DNA damage and/or its repair. It cannot be also 
excluded that LPO accompanies the development of different types of cancer, and that its 
fingerprint stays in DNA in the form of mutations in specific sequences.  
 We also studied in vitro sequence-specific interaction of the vinyl -chloride metabolite 
chloroacetaldehyde (CAA) with human TP53 gene exons 5-8, using DNA Polymerase 
Fingerprint Analysis (DPFA), and identified sites of the highest sensitivity for modification 
using ethenoadducts-specific DNA glycosylases [51]. CAA-induced DNA damage was more 
extensive in TP53 regions which revealed secondary structure perturbations, and were 
localized in regions of mutation hot-spots. These perturbations inhibited DNA synthesis on 
undamaged template as well, suggesting that they may be the fragile sites for acquisition of 
mutations due to the easier induction of lesions in these DNA sequences and/or substitution of  
replicative DNA polymerases with  DNA polymerases of lower fidelity, which incorporate 
non-cognate nucleotides [52]. 
 Choudhury and coworkers [40] established that the half time of elimination of  trans-4-
hydroxynonenal-induced cyclic 1,N2-propanodeoxyguanine DNA adducts by HeLa cells 
nuclear extract was 3 h in 30°C. This  repair was performed by nucleotide excision repair 
system, as the extracts from XPA deficient cells did not eliminate the lesion from DNA. 
Interestingly, repair was stereospecific, two stereoisomers were removed from DNA more 
efficiently that the other two.  
 
7. Translesion synthesis of exocyclic-DNA adducts and their mutagenic potency 
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 14
 The presence of unsubstituted etheno-adducted DNA bases in the template relatively 
mildly inhibits DNA synthesis by replicative and damage-specific DNA polymerases, while 
substituted etheno-type and propano-type cyclic adducts pose a strong barrier for replication 
[53, 54]. 
Ethenoadducts are mutagenic, however prokaryotic and eukaryotic DNA polymerases 
may behave differently when replicating DNA containing ethenoadducts. In bacteria, 1,N6-
ethenoadenine is mostly recognized as unmodified adenine by DNA polymerases, and 
infrequently (about 0.1%), even under SOS conditions (conditions of decreased replication 
fidelity caused by production of the elevated amounts of damage specific DNA polymerases 
of the Y family), gives rise to A:T → G:C transitions [55] or A:T → T:A and A:T → C:G 
transversions, as well as to one-nucleotide deletions [56]. In contrast, in simian kidney (COS) 
cells 70% of εA residues in DNA are replicated erroneously, giving rise to 63% of 
A:T → G:C transitions and to only 7% of other base-pair substitutions [56]. Mutagenic 
specificity of εA depends also on its position on leading and lagging strand during DNA 
replication. In human HeLa cells A:T → Τ:Α transversions were the most frequent (7%) on 
the leading strand, although A:T → C:G and A:T → G:C base pair substitutions were also 
numerous (5% and 2%, respectively) [57]. 
 Ethenocytosine in site-directed mutagenesis experiments in E. coli and mammalian 
cells gave rise to 1.5 or 2% of targeted mutagenic events in non SOS-induced E. coli cells [55, 
58], 30% in SOS-induced ones, and 81% in simian kidney cells [58, 59]. The predominant 
mutations generated by εC in both E. coli and COS cells were C:G → A:T transversions and 
C:G → T:A transitions. 
N2,3-ethenoguanine induced G:C → A:T transitions and 1,N2-ethenoguanine induced 
G:C → A:T, G:C → T:A and G:C → C:G base-pair substitutions both in primer extension 
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 15
assays with purified DNA polymerases and in E. coli cells [60-62]. Additionally, 1,N2-εG 
generated in vitro one- and two-nucleotide deletions [63]. 
Treatment of mammals with compounds inducing etheno DNA adducts, additionally 
triggers chromosomal aberrations and recombination [64]. It was shown that εA when present 
in DNA strongly stimulates the activity of topoisomerase II, causing DNA strand breaks [65].  
 Substituted LPO-derived cyclic DNA adducts, like HNE-DNA adducts strongly inhibit 
DNA synthesis by prokaryotic and eukaryotic DNA polymerases both in vitro and in cellular 
models [38, 39]. In bacteria HNE increased the mutation rate in the lacZ gene of M13 phage 
transfected into wild type E. coli strain. The most frequent events were recombinations, base 
substitutions and frameshifts. Over 50% of base substitutions were C →T transitions followed 
by G → C and A → C transvertions, which suggests that HNE adducts to all DNA bases are a 
source of point mutations, as well as trigger recombination events [38, 39]. In E. coli HNE 
induces the SOS system [66] with low fidelity DNA polymerases, Pol IV and Pol V, which 
can bypass different DNA lesions, thus enabling the cell to survive under stress conditions. 
The third SOS E. coli DNA polymerase, Pol II, is the enzyme of high fidelity. Detailed 
analysis of the contribution of SOS DNA polymerases in the induction of mutations on HNE 
damaged templates revealed that Pol IV can bypass HNE-DNA adducts in an error-free 
manner. Pol II and Pol V are strongly blocked by the presence of these adducts. The 
infrequent bypass by Pol II is error-free, while by Pol V is error-prone. Both Pol II and Pol IV 
can compete with Pol V decreasing mutation rate on HNE-adducted templates [67]. 
 Cooperation of low-fidelity DNA polymerases in bypassing HNE-DNA adducts was 
also observed in eukaryotic cells. Pol ι was able to incorporate correctly matched nucleotide 
opposite the HNE-dG adduct, although it was not able to elongate the synthesized DNA 
strand and fell off the template. Pol κ, in turn, could elongate the HNE-dG:dC pair, which 
ensured further DNA synthesis [54].  In this way the HNE-dG adducts were bypassed by two 
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 16
damage-specific DNA polymerases in an error-free manner. This may, at least partially 
explain the fact that HNE is the least mutagenic LPO product, however due to the fact that it 
is also able to modify proteins, the most cytotoxic  [20]. 
 
8. LPO-induced DNA damage in human pathological processes 
Constantly growing body of evidence indicates that LPO products are engaged in 
human pathology. Much of these data is devoted specifically to HNE and different aspects of 
its reactivity. Measurements of protein adducts, DNA adducts and levels of free HNE in 
human blood and tissues were performed. Presently there are nearly forty human diseases 
(neurodegenerative, hepatic, cardiovascular, metabolic and many others) in which increased 
HNE steady state levels have been detected [20]. 
 
8.1. Exocyclic-DNA adducts, oxidative stress and cancer 
The most abundant LPO-derived DNA adducts like propanoadducts to guanine and, to 
a lesser extent, ethenoadducts, were found in many tissues of rodents and humans as 
background DNA lesions [68]. However, there are also examples that in some conditions 
DNA ethenoadducts can be generated in the organism above the basic levels. Accumulation 
of DNA ethenoadducts was reported in LEC rats, in which copper dependent induction of 
oxidative stress via Fenton reaction occurs [69]. Similarly, an increase in ethenoadducts levels 
was correlated with oxidative stress in OXYS rats overproducing ROS [70], and was reported 
in spleen of SJL mice stimulated to overproduce nitric oxide (6-fold elevated for both εA and 
εC lesions) [71]. The most recent paper on this issue reports that in SJL mice inflammation 
model, lipid peroxidation derived DNA lesions dominate over DNA oxidation and DNA 
deamination products. Importantly, DNA ethenoadducts (εA and 1,N2-εG) were found to be 
elevated 3-4 fold not only in organs that were targeted by inflammatory processes, but also in 
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 17
kidneys, which are not directly affected by the inflammation. It was concluded that oxidative 
and nitrosative stresses associated with inflammation can affect tissues at a distance from the 
activated macrophages responsible for NO overproduction during chronic inflammation [72]. 
Oxidative stress and LPO-derived DNA damage can play an important role in cancer 
development, especially in cancers where inflammatory processes are a characteristic 
component of their etiopathogenesis [73]. In the animal model positive correlation between 
the level of ethenoadduct DNA lesions and lipoxygenase-catalyzed metabolites of arachidonic 
acid was established in the study on multistage mouse skin carcinogenesis [74]. Since then, 
numerous studies showed that in several human diseases predisposing to cancer, the levels of 
ethenoadducts in cancer prone tissues were elevated (Table 1) 
From the clinical perspective all these diseases are associated with chronic 
inflammatory processes and high risk of cancer development. On the molecular level they are 
considered as malfunctions that lead to oxidative stress in cells of the targeted organ.  
Currently it is postulated that persistent oxidative stress and lipid peroxidation  
induced by inflammation, metal storage diseases and unbalanced diet lead to accumulation of 
DNA lesions from endogenous sources. Under conditions of chronic and long term 
occurrence of these risk factors, perpetuation of carcinogenesis or progression of cancer to 
full malignancy is possible [75, 76]. 
 
9. Repair of LPO derived DNA lesions  
DNA is under permanent control of several defense systems, which have been 
developed to protect the genome from mutagenic modifications. DNA repair systems are 
specialized in repair of almost all possible damages, and the choice of the repair pathway 
depends on the structure of the damage. Bulky adducts are repaired by Nucleotide Excision 
Repair pathway (NER) [77], double strand breaks and interstrand cross-link may be processed 
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 18
by Non Homologous End Joining (NHEJ) or Homologous Recombination (HR) [78], whereas 
most of the small DNA lesions are repaired by the Base Excision Repair or by direct reversal 
(alkyltransferases, dioxygenases) [79].  
In repair of LPO-induced DNA damage probably all above-mentioned DNA repair 
systems are engaged. This is due to a variety of the types of DNA lesions induced by LPO 
products.  
 
9.1. Repair of etheno-DNA adducts by BER enzymes 
BER is a DNA repair pathway dedicated to processing of small base lesions derived 
from oxidation and alkylation that cause only little distortion in the DNA helix. In a classical 
view it consists of five steps: (I) lesion recognition, (II) excision of the damaged base, (III) 
AP site incision and removal of the chemical residues that could block further steps of the 
pathway, (IV) incorporation of the proper nucleotide(s) by DNA polymerases and (V) ligation 
of the DNA strand to restore the original DNA molecule [80-83].  
Damaged bases are recognized by DNA glycosylases. Glycosylases are specialized 
enzymes capable of processing a wide range of oxidative and alkylated bases. Presently, 13 
human DNA glycosylases with different, but partially overlapping substrate specificity have 
been identified. Several are engaged in repair of etheno-DNA adducts. All of them are 
monofunctional DNA glycosylases, and excise damaged base leaving behind an abasic (AP) 
site. AP site is subsequently recognized by the next enzyme in the BER pathway, AP-
endonuclease, which cleaves phosphodiester bond 5' to the AP site initiating further repair 
steps, deoxyribose excision, filling the gap and ligation.  
εA is excised by alkylpurine-DNA-N-glycosylase (ANPG) [84], whereas εC by 
thymine-DNA-glycosylase (TDG); the latter also excises thymine from G:T pairs, resulting 
from deamination of 5-methylcytosine [85]. Ethenocytosine is also excised by single-stranded 
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 19
uracil DNA glycosylase, SMUG1 [86] and by MBD4 glycosylase, although activity of the 
latter is strongly limited to CpG islands [87, 88]. 
ANPG glycosylase has a wide substrate specificity, and besides εA excises from DNA 
also 1,N2-ethenoguanine [89], hypoxanthine and the alkylated bases, 3-methyladenine and 7-
methylguanine [84]. TDG excises εC, T and U from pairs with guanine, and its activity is 
strongly stimulated by the next enzyme in the BER pathway, AP-endonuclease, APE1 [90]. 
TDG and APE1 also play the role of transcription regulators [91-94]  
Ethenocytosine repair by the BER system is dependent not only on the level and 
activity of TDG, MBD4 or SMUG1 DNA glycosylases, but also on the presence and/or 
activity of ANPG glycosylase, which primary substrate is εA. ANPG binds strongly to DNA 
containing εC, and although does not excise this modified base, does not allow its excision by 
the proper εC glycosylase, like TDG [95]. This may explain observation that the level of εC 
measured in different human tissues was constantly higher than that of εA [96]. 
 
 9.1.1. Repair of etheno-DNA adducts by BER system and human cancers 
We compared repair of εA, εC and 8-oxoguanine (8-oxoG) in polymorphic blood 
leukocytes of non-small cell lung cancer (NSCLC) patients and healthy volunteers. The major 
histological subtypes of NSCLC are squamous cell carcinoma (SQ), which ethiology is 
strongly linked to tobacco smoking, and adenocarcinoma (AD), which is related to chronic 
inflammations, infections and healing of scars, although, the majority of lung cancer patients 
in Western countries are tobacco smokers or past smokers. The most striking finding of the 
study was observation that blood leukocytes repair capacity for εA and 8-oxoG was 
significantly lower in lung cancer patients than in healthy volunteers [97, 98]. Consistently, 8-
oxoG level in cancer patients leukocytes was higher than that in healthy controls. This showed 
that deficient repair of oxidative DNA damage may be a risk factor for the development of 
Page 22 of 58
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
 
 20
lung cancer. Surprisingly, εC repair rate was the same in the leukocytes of cancer patients and 
healthy controls. However, in individuals developing AD, εC repair was significantly 
decreased. Also, εA repair activity was markedly lower in the leukocytes of AD patients than 
in SQ patients and healthy controls. Comparing repair rates in lung tissues of cancer patients, 
similar differences were observed between histological types of cancer.  εA and εC-repair 
activities were significantly lower in normal lung of individuals suffering from AD than from 
SQ. Interestingly, no such differences were observed in repair rates of 8-oxoguanine. This 
suggests that the etiology of lung adenocarcinoma may be related to inefficient repair of 
exocyclic DNA adducts, deriving from lipid peroxidation. Very few other studies have linked 
LPO with the progression of lung cancer, and our study showed, for the first time, the 
association between the deficiency of specific repair pathways for εA and εC with the 
development of specific histological type of tumor. 
No difference in εA and εC level between tumor and non-affected lung tissues was 
recorded, and this could be due to compensating increase of repair activities in the tumor. No 
significant differences in εA and εC level as well as r pair activities were associated with age, 
gender and smoking habit. 
Thus results obtained in that study suggested that oxidative stress contributes to induction 
and/or progression of lung cancer, and that repair deficiency for εA and εC is associated 
particularly with the development of lung adenocarcinoma.  
 Similarly, εA and εC repair rates were decreased in PBL of colorectal carcinoma 
(CRC) patients in comparison to healthy controls, suggesting that such decreased repair rate 
could be one of the risk factors for CRC development [99]. Indeed, inflammation and high fat 
diet are the major risk factors for CRC development. Surprisingly, εA and 1,N2-εG level was 
also lower in PBL of CRC patients than in healthy controls. This could suggest that  apart 
from the BER system, ethenoadducts are eliminated from DNA by other repair activities, 
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which are induced in cancer patients. Good candidates are dioxygenases of AlkB family. 
Their level was significantly increased in some types of cancer e.g. prostate cancer [100, 101] 
however their contribution to repair of exocyclic DNA adducts in mammals still is not clear. 
 
9.1.2. Oxidative dealkylation by AlkB enzymes 
It was demonstrated that AlkB protein from Escherichia coli, which removes alkyl 
groups by direct reversal without DNA scission and resynthesis, repairs also εA and εC [102-
104]. Cellular functions of numerous members of this group of enzymes is poorly elaborated, 
and it is not well understood to what extent they participate in repair of exocyclic DNA 
adducts. The data obtained for E. coli  suggest that in this bacteria AlkB is at least as 
important as BER in the elimination of etheno-type, unsubstituted exocyclic DNA adducts 
[105]. 
Dioxygenases from AlkB family remove alkyl groups from DNA by oxidative 
dealkylation in the reaction, which requires oxygen, 2-oxoglutarate and Fe2+ ions  [2, 106]. E. 
coli AlkB protein catalyses oxidation of cytotoxic alkyl groups in ssDNA, dsDNA as well as 
in RNA, which leads to the reconstitution of intact base and liberation of oxidized alkyl 
group, e.g. formaldehyde or glyoxal (Fig. 9) [2]. The main DNA lesions repaired by E. coli 
AlkB protein are 1MeA and 3MeC, but the enzyme also repairs 1MeG, 3MeT, as well as 
removes ethyl, propyl, hydroxypropyl groups and etheno-groups from exocyclic DNA 
adducts, εA and εC [104, 107-109]. The enzyme removes also alkyl groups from mRNA and 
tRNA [110]. 
AlkB proteins were found in most organisms from RNA viruses to humans. In silico 
search revealed the existence of nine AlkB homologues in human genome, ABH1-8 [111] and 
the product of human obesity gene, FTO [112]. Biological functions of these proteins are not 
completely understood, however hABH1, hABH2, hABH3 and FTO were proven to have 
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enzymatic activities dealkylating DNA or RNA [113]. ABH2 and ABH3 similarly to AlkB 
dealkylate 1MeA, 3MeC, 1MeG, 1MeT and 1-EtA in DNA, and ABH3 repairs RNA as well 
[106, 114, 115]. The best substrate for ABH3 is 3MeC and this lesion is preferentially 
repaired in ssDNA [106, 116]. ABH2 eliminates more efficiently 1MeA than 3MeC, and 
repair is more efficient when the lesion is localized in dsDNA than in ssDNA [114]. hABH2 
eliminates also εA from ds and ssDNA [117], and thus may be a backup enzyme for ANPG 
glycosylase. Recently, it was  shown that hABH2 repairs εC, as well, and probably competes 
with ANPG in the access to the lesion, since ANPG inhibits in vitro repair of εC by ABH2 
[118]. It is, however necessary to stress, that repair of etheno-DNA adducts by AlkB proteins 
is much less efficient than repair of methylated bases. ABH2 was found in replication foci, 
and contains a motif to bind PCNA [119]. The function of ABH2 might be to clean the 
template or alternatively participate in replication regulation.  
ABH2 and ABH3 knockout mice are viable with phenotype similar to that of the wild 
type animals. ABH2 knockout mice accumulate 1MeA with age [120]. However, no 
accumulation of εA was found both in ABH2 and ABH3 deficient mice. In contrast, a 
significant increase of εA level was observed in DNA of ANPG deficient mice [120]. This 
suggests that in spite of the possibility to repair εA in vitro, in vivo ABH2 is not able to cope 
with endogenously formed εA.  
ABH1 is a mitochondrial protein and removes 3MeC from ssDNA and RNA [121]. 
Recent studies suggest that ABH1 may also possess a lyase activity [122].  
FTO dealkylates 3MeT and 3MeU in ssDNA and RNA [123], as well as N6-MeA in 
ssDNA and RNA [124]. It is suggested that in higher eukaryotes FTO may be a major 
enzyme, which removes methyl group from  N6-MeA in mRNA. 
ABH8 besides 2-oxoglutarate/Fe2+-dependent dioxygenase domain contains also RNA 
binding domain and methyltransferase domain. The protein is a tRNA methyltransferase 
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required for the final step in the biogenesis of 5-methoxycarbonyl-methyluridine (mcm5(U)). 
The interaction of ALKBH8 with a small accessory protein, TRM112, is required to form a 
functional tRNA methyltransferase [125]. mcm5(U) is frequently found in the wobble position 
of uridine, and may change the efficiency of translation of certain proteins [126]. Dioxygenase 
activity of ABH8 participates in hydroxylation of mcm5(U) and its derivative 5-
methoxycarbonylmethyl-2-thiouridine (mcm5s2U) to yield 5-(S)-[methoxycarbonyl-
(hydroxy)methyl]uridine ((S)-mchm5U) [127]. 
AlkB proteins may also play divergent roles not related to modification of nucleic 
acids. ABH1 homologue participates in differentiation of trophoblast stem cells and in the 
epigenetic regulation of transcription [128]. ABH3 was recognized as prostate cancer antigen 
1 (PCA-1), and many studies suggest that ABH3 may be a selective marker for malignant 
transformation in prostate [100]. Recently, it was observed that PCA-1 increases expression of 
Discoidin Domain Receptor 1, a receptor with tyrosine kinase activity, and in consequence 
promotes prostate cancer development [129].   
The function of other human AlkB homologues is obscure. Their mRNA is quite 
abundant in most tissues, particularly in testis, which suggests that these proteins may play a 
role in cell differentiation, division or other important functions, and that their role is not 
limited to DNA repair [130].  
 
9.1.3. Nucleotide excision repair and recombination  
 Bulky LPO adducts to DNA bases, like HNE adducts, which have alkyl side chains are 
repaired by nucleotide excision repair system (NER). Chung and coworkers [49, 131] showed 
that HNE-dG adducts are recognized and excised from DNA by bacterial UvrABC 
excinuclease. HNE-dG adducts were also more cytotoxic and mutagenic in NER deficient 
human and E. coli  cells than in NER proficient cells [132]. Subsequent studies in E.coli, 
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which used M13 phage model showed that HNE adducts to all DNA bases are efficiently 
repaired by E. coli NER system, however in NER deficient strain a huge increase of 
recombination events was observed [38], and mutation frequency increased significantly. This 
suggested that both NER and recombination are engaged in the elimination of deleterious 
effects of the presence of HNE-DNA adducts in genetic material. Interestingly, in E. coli 
strains deficient in repair by NER and recombination the survival of M13 phage modified 
with HNE was higher and mutation frequency lower than in the single uvrA mutant, 
suggesting the presence of a backup repair system operating in the absence of NER and 
recombination repair. The contribution of mismatch repair was excluded [38]. Next studies 
[67] showed that SOS DNA polymerases may play a role of such a backup system, since Pol 
IV and Pol II synthesized DNA faithfully on HNE damaged template in E. coli cells (see 
paragraph 7).  
 Contribution of recombination in repair of HNE-DNA adducts in mammalian cells 
was reported already in the 90-ties, since HNE was shown to induce micronuclei, sister 
chromatid exchanges and chromosomal aberrations [133-135].  
 Since most LPO-derived DNA adducts, like HNE-DNA adducts are able to form 
interstrand DNA cross-links [136], other repair systems, namely Fanconi anemia pathway 
may be engaged in repair of these DNA damages. This, however, needs further research. 
 We have also shown that the presence of bulky HNE-DNA adducts in the template 
strongly inhibits transcription by T7 RNA polymerase, and HeLa cells extract in vitro [137]. 
In contrast, unsubstituted εA did not inhibit RNA synthesis [138]. Treatment of wild type cells 
with 1-20 µM HNE caused dephosphorylation of the Cockayne syndrome complementation 
group B (CSB) protein. Such dephosphorylation stimulates its ATPase activity of the CSB 
protein necessary for transcription-coupled repair  (TCR), a quick NER subpathway that 
preferentially removes lesions from transcribed DNA strand. The deficiency of CSB  protein 
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leads to progressive multisystem degeneration and premature aging [139]. Cell lines 
expressing CSB protein mutated in different ATPase domains exhibited different sensitivities 
to HNE. The motif II mutant, which binds ATP, but is defective in ATP hydrolysis was as 
sensitive to HNE as CSB-null cells. In contrast, motif V mutant cells were as sensitive to 
HNE as were the cells bearing wild type protein, while motif VI mutant cells showed 
intermediate sensitivity to HNE. These mutants exhibit decreased ATP binding, but retain 
residual ATPase activity. In addition, CSB-deficient cells were hypersensitive to 
physiological concentrations of HNE, and developed a higher level of sister chromatid 
exchanges in comparison to the wild type cells [137]. These results strongly suggest that 
HNE-DNA adducts are endogenous DNA lesions, blocking transcription in mammalian cells 
and are processed by the TCR system. Thus, HNE, and possibly other LPO products, might 
also be  endogenously formed compounds contributing to accelerated aging and degeneration. 
Indeed, increased level of HNE accumulation was observed in brain tissue and in cerebrum of 
patients suffering from several neurodegenerative disorders like Alzheimer’s, Parkinson’s, 
Pick’s, amyotrophic lateral sclerosis and Huntington diseases [140]. Interestingly, large 
amounts of HNE-modified proteins were found in the brains (globus pallidus) of Cockayne 
syndrome patients [141]. 
  DNA repair proteins may also be targeted by LPO products, however, literature data 
on this issue are rather limited. Feng and coworkers [142] have shown that treatment of cells 
with HNE inhibits elimination of UV dimers and benzo[a]pyrenediol epoxide-guanine 
adducts from DNA, suggesting that NER may be inhibited in mammalian cells by elevated 
HNE concentrations. We have also demonstrated that high HNE concentrations (100-200 µM) 
inhibit in vitro ATPase activity of the CSB protein as well as the transcription machinery in 
HeLa cell-free extracts [137]. Inhibition of cellular repair capacity by LPO products may be 
an important, additional mechanism of pro-carcinogenic consequences of inflammation. 
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10. Conclusions 
 Lipid peroxidation generates plethora of reactive aldehydes, which are relatively stable 
and bind to nucleic acids, proteins and cellular thiols. As far as mutagenic properties were 
shown for the majority of etheno- and propano-type adducts to DNA bases, the adverse 
effects of LPO on human health remains controversial. Etheno-DNA adducts were elevated in 
cancer-prone human diseases, and carcinogenic properties were described for chemical 
compounds introducing ethenoadducts to DNA bases, e.g. vinyl chloride. Adducts to DNA 
bases of longer LPO products, like HNE, very efficiently block transcription by prokaryotic 
and eukaryotic transcription machineries, and may favor cell senescence, and possibly aging 
of organisms and neurodegenerative processes. In addition, HNE binds to proteins, and may 
change cellular transcription and signaling and this may depend on compound concentration. 
At high concentrations HNE inhibits repair of bulky adducts, which may be introduced to 
DNA by UV light, several environmental carcinogens, like benzo[a]pyrene, as well as LPO 
products, this way sensitizing cells to other mutagenic and carcinogenic exposures. On the 
other hand, increased HNE levels in cells also promote apoptotic signaling, while at decreased 
concentration, below its basal constituted levels, HNE promotes proliferation. It was shown 
that by blocking detoxification of HNE through the inhibition of RLIP76 catalyzed transport 
of glutathione-HNE out of the cell, a complete remission of many human cancer xenografts in 
mice was achieved [143]. HNE was also shown to inhibit telomerase activity in colon 
carcinoma cell lines [144] and in human leukemic cells [145]. This occurred  by the reduction 
of GSH content, and by the modulation of expression and activity of transcription factors 
belonging to the Myc/Mad/Max network. Since the presence of PUFAs in the diet exposes 
epithelial colon cells to HNE, this aldehyde could contribute to cell growth control through 
the inhibitory action on telomerase activity and its expression, suggesting a protective effect 
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on colon mucosa. Understanding of these processes in future may contribute to the 
improvement of cancer therapy. 
 
11. Acknowledgments 
This work was supported by Polish-French grant project 346/N-INCA/2008/0. 
12. References 
[1] Lindahl T. Instability and decay of the primary structure of DNA. Nature 1993;362:709-
715 
[2] Sedgwick B, Bates PA, Paik J, Jacobs SC, Lindahl T. Repair of alkylated DNA: recent 
advances. DNA Repair (Amst) 2007;6:429-442 
[3] Tudek B, Winczura A, Janik J, Siomek A, Foksinski M, Olinski R. Involvement of 
oxidatively damaged DNA and repair in cancer development and aging. Am J Transl Res 
2010;2:254-284 
[4] Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and 
antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006;160:1-40 
[5] Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and 
antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 
2007;39:44-84 
[6] Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA 
damage and cancer incidence. Mol Cell Biochem 2004;266:37-56 
[7] Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid 
Res 2003;42:318-343 
[8] Burcham PC. Genotoxic lipid peroxidation products: their DNA damaging properties and 
role in formation of endogenous DNA adducts. Mutagenesis 1998;13:287-305 
Page 30 of 58
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
 
 28
[9] Marnett LJ. Lipid peroxidation-DNA damage by malondialdehyde. Mutat Res 
1999;424:83-95 
[10] Schaur RJ. Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol 
Aspects Med 2003;24:149-159 
[11] Brigelius-Flohe R. Glutathione peroxidases and redox-regulated transcription factors. 
Biol Chem 2006;387:1329-1335 
[12] Yoo MH, Gu X, Xu XM, Kim JY, Carlson BA, Patterson AD, Cai H, Gladyshev VN, 
Hatfield DL. Delineating the role of glutathione peroxidase 4 in protecting cells against lipid 
hydroperoxide damage and in Alzheimer's disease. Antioxid Redox Signal 2010;12:819-827 
[13] Vieira FG, Di Pietro PF, Boaventura BC, Ambrosi C, Rockenbach G, Fausto MA, Crippa 
CG, Da Silva EL. Factors associated with oxidative stress in women with breast cancer. Nutr 
Hosp 2011;26:528-536 
[14] Krzystek-Korpacka M, Salmonowicz B, Boehm D, Berdowska I, Zielinski B, Patryn E, 
Noczynska A, Gamian A. Diagnostic potential of oxidative stress markers in children and 
adolescents with type 1 diabetes. Clin Biochem 2008;41:48-55 
[15] Katalinic V, Salamunic I, Pazanin S, Mulic R, Milisic M, Ropac D. The antioxidant 
power and level of lipid peroxidation products in the sera of apparently healthy adult males. 
Coll Antropol 2007;31:165-171 
[16] Gautam N, Das S, Mahapatra SK, Chakraborty SP, Kundu PK, Roy S. Age associated 
oxidative damage in lymphocytes. Oxid Med Cell Longev 2010;3:275-282 
[17] Schneider C, Tallman KA, Porter NA, Brash AR. Two distinct pathways of formation of 
4-hydroxynonenal. Mechanisms of nonenzymatic transformation of the 9- and 13-
hydroperoxides of linoleic acid to 4-hydroxyalkenals. J Biol Chem 2001;276:20831-20838 
[18] Schneider C, Pratt DA, Porter NA, Brash AR. Control of oxygenation in lipoxygenase 
and cyclooxygenase catalysis. Chem Biol 2007;14:473-488 
Page 31 of 58
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
 
 29
[19] Noguchi N, Yamashita H, Hamahara J, Nakamura A, Kuhn H, Niki E. The specificity of 
lipoxygenase-catalyzed lipid peroxidation and the effects of radical-scavenging antioxidants. 
Biol Chem 2002;383:619-626 
[20] Poli G, Schaur RJ, Siems WG, Leonarduzzi G. 4-hydroxynonenal: a membrane lipid 
oxidation product of medicinal interest. Med Res Rev 2008;28:569-631 
[21] Yang Y, Sharma R, Sharma A, Awasthi S, Awasthi YC. Lipid peroxidation and cell 
cycle signaling: 4-hydroxynonenal, a key molecule in stress mediated signaling. Acta 
Biochim Pol 2003;50:319-336 
[22] Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, 
malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81-128 
[23] Siems WG, Zollner H, Grune T, Esterbauer H. Metabolic fate of 4-hydroxynonenal in 
hepatocytes: 1,4-dihydroxynonene is not the main product. J Lipid Res 1997;38:612-622 
[24] Jung T, Engels M, Kaiser B, Grune T. Distribution of oxidized and HNE-modified 
proteins in U87 cells. Biofactors 2005;24:165-170 
[25] Parola M, Robino G, Marra F, Pinzani M, Bellomo G, Leonarduzzi G, Chiarugi P, 
Camandola S, Poli G, Waeg G, Gentilini P, Dianzani MU. HNE interacts directly with JNK 
isoforms in human hepatic stellate cells. J Clin Invest 1998;102:1942-1950 
[26] Uchida K, Shiraishi M, Naito Y, Torii Y, Nakamura Y, Osawa T. Activation of stress 
signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a 
potential inducer of intracellular peroxide production. J Biol Chem 1999;274:2234-2242 
[27] Suc I, Meilhac O, Lajoie-Mazenc I, Vandaele J, Jurgens G, Salvayre R, Negre-Salvayre 
A. Activation of EGF receptor by oxidized LDL. Faseb J 1998;12:665-671 
[28] Robino G, Parola M, Marra F, Caligiuri A, De Franco RM, Zamara E, Bellomo G, 
Gentilini P, Pinzani M, Dianzani MU. Interaction between 4-hydroxy-2,3-alkenals and the 
Page 32 of 58
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
 
 30
platelet-derived growth factor-beta receptor. Reduced tyrosine phosphorylation and 
downstream signaling in hepatic stellate cells. J Biol Chem 2000;275:40561-40567 
[29] Chiarpotto E, Domenicotti C, Paola D, Vitali A, Nitti M, Pronzato MA, Biasi F, 
Cottalasso D, Marinari UM, Dragonetti A, Cesaro P, Isidoro C, Poli G. Regulation of rat 
hepatocyte protein kinase C beta isoenzymes by the lipid peroxidation product 4-hydroxy-2,3-
nonenal: A signaling pathway to modulate vesicular transport of glycoproteins. Hepatology 
1999;29:1565-1572 
[30] Grune T, Davies KJ. The proteasomal system and HNE-modified proteins. Mol Aspects 
Med 2003;24:195-204 
[31] Okada K, Wangpoengtrakul C, Osawa T, Toyokuni S, Tanaka K, Uchida K. 4-Hydroxy-
2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. 
Identification of proteasomes as target molecules. J Biol Chem 1999;274:23787-23793 
[32] Awasthi YC, Sharma R, Sharma A, Yadav S, Singhal SS, Chaudhary P, Awasthi S. Self-
regulatory role of 4-hydroxynonenal in signaling for stress-induced programmed cell death. 
Free Radic Biol Med 2008;45:111-118 
[33] Liu W, Akhand AA, Kato M, Yokoyama I, Miyata T, Kurokawa K, Uchida K, 
Nakashima I. 4-hydroxynonenal triggers an epidermal growth factor receptor-linked signal 
pathway for growth inhibition. J Cell Sci 1999;112 ( Pt 14):2409-2417 
[34] West JD, Marnett LJ. Alterations in gene expression induced by the lipid peroxidation 
product, 4-hydroxy-2-nonenal. Chem Res Toxicol 2005;18:1642-1653 
[35] Chenna A, Iden CR. Characterization of 2'-deoxycytidine and 2'-deoxyuridine adducts 
formed in reactions with acrolein and 2-bromoacrolein. Chem Res Toxicol 1993;6:261-268 
[36] Chenna A, Rieger RA, Iden CR. Characterization of thymidine adducts formed by 
acrolein and 2-bromoacrolein. Carcinogenesis 1992;13:2361-2365 
Page 33 of 58
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
 
 31
[37] Barbin A, Bartsch H, Leconte P, Radman M. Studies on the miscoding properties of 
1,N6-ethenoadenine and 3,N4-ethenocytosine, DNA reaction products of vinyl chloride 
metabolites, during in vitro DNA synthesis. Nucleic Acids Res 1981;9:375-387 
[38] Janowska B, Komisarski M, Prorok P, Sokolowska B, Kusmierek J, Janion C, Tudek B. 
Nucleotide excision repair and recombination are engaged in repair of trans-4-hydroxy-2-
nonenal adducts to DNA bases in Escherichia coli. Int J Biol Sci 2009;5:611-620 
[39] Kowalczyk P, Ciesla JM, Komisarski M, Kusmierek JT, Tudek B. Long-chain adducts of 
trans-4-hydroxy-2-nonenal to DNA bases cause recombination, base substitutions and 
frameshift mutations in M13 phage. Mutat Res 2004;550:33-48 
[40] Choudhury S, Pan J, Amin S, Chung FL, Roy R. Repair kinetics of trans-4-
hydroxynonenal-induced cyclic 1,N2-propanodeoxyguanine DNA adducts by human cell 
nuclear extracts. Biochemistry 2004;43:7514-7521 
[41] Sodum RS, Chung FL. Stereoselective formation of in vitro nucleic acid adducts by 2,3-
epoxy-4-hydroxynonanal. Cancer Res 1991;51:137-143 
[42] Fernandes PH, Wang H, Rizzo CJ, Lloyd RS. Site-specific mutagenicity of 
stereochemically defined 1,N2-deoxyguanosine adducts of trans-4-hydroxynonenal in 
mammalian cells. Environ Mol Mutagen 2003;42:68-74 
[43] Zhang S, Balbo S, Wang M, Hecht SS. Analysis of acrolein-derived 1,N2-
propanodeoxyguanosine adducts in human leukocyte DNA from smokers and nonsmokers. 
Chem Res Toxicol 2011;24:119-124 
[44] Stein S, Lao Y, Yang IY, Hecht SS, Moriya M. Genotoxicity of acetaldehyde- and 
crotonaldehyde-induced 1,N2-propanodeoxyguanosine DNA adducts in human cells. Mutat 
Res 2006;608:1-7 
[45] Chen HJ, Chung FL. Formation of etheno adducts in reactions of enals via autoxidation. 
Chem Res Toxicol 1994;7:857-860 
Page 34 of 58
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
 
 32
[46] Nair J, Nair UJ, Sun X, Wang Y, Arab K, Bartsch H. Quantifying etheno-DNA adducts 
in human tissues, white blood cells, and urine by ultrasensitive (32)P-postlabeling and 
immunohistochemistry. Methods Mol Biol 2011;682:189-205 
[47] Bartsch H, Nair J. Accumulation of lipid peroxidation-derived DNA lesions: potential 
lead markers for chemoprevention of inflammation-driven malignancies. Mutat Res 
2005;591:34-44 
[48] Lee SH, Arora JA, Oe T, Blair IA. 4-Hydroperoxy-2-nonenal-induced formation of 
1,N2-etheno-2'-deoxyguanosine adducts. Chem Res Toxicol 2005;18:780-786 
[49] Chung FL, Pan J, Choudhury S, Roy R, Hu W, Tang MS. Formation of trans-4-hydroxy-
2-nonenal- and other enal-derived cyclic DNA adducts from omega-3 and omega-6 
polyunsaturated fatty acids and their roles in DNA repair and human p53 gene mutation. 
Mutat Res 2003;531:25-36 
[50] Tudek B, Kowalczyk P, Ciesla JM. Localization of chloroacetaldehyde-induced DNA 
damage in human p53 gene by DNA polymerase fingerprint analysis. IARC Sci Publ 
1999;279-293 
[51] Kowalczyk P, Ciesla JM, Saparbaev M, Laval J, Tudek B. Sequence-specific p53 gene 
damage by chloroacetaldehyde and its repair kinetics in Escherichia coli. Acta Biochim Pol 
2006;53:337-347 
[52] Goodman MF. Error-prone repair DNA polymerases in prokaryotes and eukaryotes. 
Annu Rev Biochem 2002;71:17-50 
[53] Hang B, Chenna A, Guliaev AB, Singer B. Miscoding properties of 1,N6-ethanoadenine, 
a DNA adduct derived from reaction with the antitumor agent 1,3-bis(2-chloroethyl)-1-
nitrosourea. Mutat Res 2003;531:191-203 
Page 35 of 58
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
 
 33
[54] Wolfle WT, Johnson RE, Minko IG, Lloyd RS, Prakash S, Prakash L. Replication past a 
trans-4-hydroxynonenal minor-groove adduct by the sequential action of human DNA 
polymerases iota and kappa. Mol Cell Biol 2006;26:381-386 
[55] Basu AK, Wood ML, Niedernhofer LJ, Ramos LA, Essigmann JM. Mutagenic and 
genotoxic effects of three vinyl chloride-induced DNA lesions: 1,N6-ethenoadenine, 3,N4-
ethenocytosine, and 4-amino-5-(imidazol-2-yl)imidazole. Biochemistry 1993;32:12793-12801 
[56] Pandya GA, Moriya M. 1,N6-ethenodeoxyadenosine, a DNA adduct highly mutagenic in 
mammalian cells. Biochemistry 1996;35:11487-11492 
[57] Levine RL, Yang IY, Hossain M, Pandya GA, Grollman AP, Moriya M. Mutagenesis 
induced by a single 1,N6-ethenodeoxyadenosine adduct in human cells. Cancer Res 
2000;60:4098-4104 
[58] Moriya M, Zhang W, Johnson F, Grollman AP. Mutagenic potency of exocyclic DNA 
adducts: marked differences between Escherichia coli and simian kidney cells. Proc Natl 
Acad Sci U S A 1994;91:11899-11903 
[59] Palejwala VA, Simha D, Humayun MZ. Mechanisms of mutagenesis by exocyclic DNA 
adducts. Transfection of M13 viral DNA bearing a site-specific adduct shows that 
ethenocytosine is a highly efficient RecA-independent mutagenic noninstructional lesion. 
Biochemistry 1991;30:8736-8743 
[60] Singer B, Kusmierek JT, Folkman W, Chavez F, Dosanjh MK. Evidence for the 
mutagenic potential of the vinyl chloride induced adduct, N2, 3-etheno-deoxyguanosine, 
using a site-directed kinetic assay. Carcinogenesis 1991;12:745-747 
[61] Langouet S, Mican AN, Muller M, Fink SP, Marnett LJ, Muhle SA, Guengerich FP. 
Misincorporation of nucleotides opposite five-membered exocyclic ring guanine derivatives 
by escherichia coli polymerases in vitro and in vivo: 1,N2-ethenoguanine, 5,6,7,9-tetrahydro-
Page 36 of 58
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
 
 34
9-oxoimidazo[1, 2-a]purine, and 5,6,7,9-tetrahydro-7-hydroxy-9-oxoimidazo[1, 2-a]purine. 
Biochemistry 1998;37:5184-5193 
[62] Cheng KC, Preston BD, Cahill DS, Dosanjh MK, Singer B, Loeb LA. The vinyl chloride 
DNA derivative N2,3-ethenoguanine produces G----A transitions in Escherichia coli. Proc 
Natl Acad Sci U S A 1991;88:9974-9978 
[63] Langouet S, Muller M, Guengerich FP. Misincorporation of dNTPs opposite 1,N2-
ethenoguanine and 5,6,7,9-tetrahydro-7-hydroxy-9-oxoimidazo[1,2-a]purine in 
oligonucleotides by Escherichia coli polymerases I exo- and II exo-, T7 polymerase exo-, 
human immunodeficiency virus-1 reverse transcriptase, and rat polymerase beta. 
Biochemistry 1997;36:6069-6079 
[64] Bartsch H, Barbin A, Marion MJ, Nair J, Guichard Y. Formation, detection, and role in 
carcinogenesis of ethenobases in DNA. Drug Metab Rev 1994;26:349-371 
[65] Sabourin M, Osheroff N. Sensitivity of human type II topoisomerases to DNA damage: 
stimulation of enzyme-mediated DNA cleavage by abasic, oxidized and alkylated lesions. 
Nucleic Acids Res 2000;28:1947-1954 
[66] Benamira M, Marnett LJ. The lipid peroxidation product 4-hydroxynonenal is a potent 
inducer of the SOS response. Mutat Res 1992;293:1-10 
[67] Janowska B, Kurpios-Piec D, Prorok P, Szparecki G, Komisarski M, Kowalczyk P, 
Janion C, Tudek B. Role of damage-specific DNA polymerases in M13 phage mutagenesis 
induced by a major lipid peroxidation product trans-4-hydroxy-2-nonenal. Mutat Res 2011; 
[68] Nair J, Barbin A, Velic I, Bartsch H. Etheno DNA-base adducts from endogenous 
reactive species. Mutat Res 1999;424:59-69 
[69] Nair J, Sone H, Nagao M, Barbin A, Bartsch H. Copper-dependent formation of 
miscoding etheno-DNA adducts in the liver of Long Evans cinnamon (LEC) rats developing 
hereditary hepatitis and hepatocellular carcinoma. Cancer Res 1996;56:1267-1271 
Page 37 of 58
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
 
 35
[70] Nair J, Sinitsina O, Vasunina EA, Nevinsky GA, Laval J, Bartsch H. Age-dependent 
increase of etheno-DNA-adducts in liver and brain of ROS overproducing OXYS rats. 
Biochem Biophys Res Commun 2005;336:478-482 
[71] Nair J, Carmichael PL, Fernando RC, Phillips DH, Strain AJ, Bartsch H. Lipid 
peroxidation-induced etheno-DNA adducts in the liver of patients with the genetic metal 
storage disorders Wilson's disease and primary hemochromatosis. Cancer Epidemiol 
Biomarkers Prev 1998;7:435-440 
[72] Pang B, Zhou X, Yu H, Dong M, Taghizadeh K, Wishnok JS, Tannenbaum SR, Dedon 
PC. Lipid peroxidation dominates the chemistry of DNA adduct formation in a mouse model 
of inflammation. Carcinogenesis 2007;28:1807-1813 
[73] Nair U, Bartsch H, Nair J. Lipid peroxidation-induced DNA damage in cancer-prone 
inflammatory diseases: a review of published adduct types and levels in humans. Free Radic 
Biol Med 2007;43:1109-1120 
[74] Nair J, Furstenberger G, Burger F, Marks F, Bartsch H. Promutagenic etheno-DNA 
adducts in multistage mouse skin carcinogenesis: correlation with lipoxygenase-catalyzed 
arachidonic acid metabolism. Chem Res Toxicol 2000;13:703-709 
[75] Bartsch H, Nair J. Chronic inflammation and oxidative stress in the genesis and 
perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair. Langenbecks 
Arch Surg 2006;391:499-510 
[76] Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C. Chronic inflammation 
and oxidative stress in human carcinogenesis. Int J Cancer 2007;121:2381-2386 
[77] Shuck SC, Short EA, Turchi JJ. Eukaryotic nucleotide excision repair: from 
understanding mechanisms to influencing biology. Cell Res 2008;18:64-72 
Page 38 of 58
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
 
 36
[78] Pardo B, Gomez-Gonzalez B, Aguilera A. DNA repair in mammalian cells: DNA 
double-strand break repair: how to fix a broken relationship. Cell Mol Life Sci 2009;66:1039-
1056 
[79] Eker AP, Quayle C, Chaves I, van der Horst GT. DNA repair in mammalian cells: Direct 
DNA damage reversal: elegant solutions for nasty problems. Cell Mol Life Sci 2009;66:968-
980 
[80] Fortini P, Dogliotti E. Base damage and single-strand break repair: mechanisms and 
functional significance of short- and long-patch repair subpathways. DNA Repair (Amst) 
2007;6:398-409 
[81] Almeida KH, Sobol RW. A unified view of base excision repair: lesion-dependent 
protein complexes regulated by post-translational modification. DNA Repair (Amst) 
2007;6:695-711 
[82] Hegde ML, Hazra TK, Mitra S. Early steps in the DNA base excision/single-strand 
interruption repair pathway in mammalian cells. Cell Res 2008;18:27-47 
[83] Robertson AB, Klungland A, Rognes T, Leiros I. DNA repair in mammalian cells: Base 
excision repair: the long and short of it. Cell Mol Life Sci 2009;66:981-993 
[84] Saparbaev M, Kleibl K, Laval J. Escherichia coli, Saccharomyces cerevisiae, rat and 
human 3-methyladenine DNA glycosylases repair 1,N6-ethenoadenine when present in DNA. 
Nucleic Acids Res 1995;23:3750-3755 
[85] Saparbaev M, Laval J. 3,N4-ethenocytosine, a highly mutagenic adduct, is a primary 
substrate for Escherichia coli double-stranded uracil-DNA glycosylase and human mismatch-
specific thymine-DNA glycosylase. Proc Natl Acad Sci U S A 1998;95:8508-8513 
[86] Kavli B, Sundheim O, Akbari M, Otterlei M, Nilsen H, Skorpen F, Aas PA, Hagen L, 
Krokan HE, Slupphaug G. hUNG2 is the major repair enzyme for removal of uracil from U:A 
Page 39 of 58
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
 
 37
matches, U:G mismatches, and U in single-stranded DNA, with hSMUG1 as a broad 
specificity backup. J Biol Chem 2002;277:39926-39936 
[87] Bellacosa A. Role of MED1 (MBD4) Gene in DNA repair and human cancer. J Cell 
Physiol 2001;187:137-144 
[88] Jiricny J, Menigatti M. DNA Cytosine demethylation: are we getting close? Cell 
2008;135:1167-1169 
[89] Saparbaev M, Langouet S, Privezentzev CV, Guengerich FP, Cai H, Elder RH, Laval J. 
1,N(2)-ethenoguanine, a mutagenic DNA adduct, is a primary substrate of Escherichia coli 
mismatch-specific uracil-DNA glycosylase and human alkylpurine-DNA-N-glycosylase. J 
Biol Chem 2002;277:26987-26993 
[90] Privezentzev CV, Saparbaev M, Laval J. The HAP1 protein stimulates the turnover of 
human mismatch-specific thymine-DNA-glycosylase to process 3,N(4)-ethenocytosine 
residues. Mutat Res 2001;480-481:277-284 
[91] Demple B, Sung JS. Molecular and biological roles of Ape1 protein in mammalian base 
excision repair. DNA Repair (Amst) 2005;4:1442-1449 
[92] Um S, Harbers M, Benecke A, Pierrat B, Losson R, Chambon P. Retinoic acid receptors 
interact physically and functionally with the T:G mismatch-specific thymine-DNA 
glycosylase. J Biol Chem 1998;273:20728-20736 
[93] Tini M, Benecke A, Um SJ, Torchia J, Evans RM, Chambon P. Association of CBP/p300 
acetylase and thymine DNA glycosylase links DNA repair and transcription. Mol Cell 
2002;9:265-277 
[94] Missero C, Pirro MT, Simeone S, Pischetola M, Di Lauro R. The DNA glycosylase T:G 
mismatch-specific thymine DNA glycosylase represses thyroid transcription factor-1-
activated transcription. J Biol Chem 2001;276:33569-33575 
Page 40 of 58
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
 
 38
[95] Gros L, Maksimenko AV, Privezentzev CV, Laval J, Saparbaev MK. Hijacking of the 
human alkyl-N-purine-DNA glycosylase by 3,N4-ethenocytosine, a lipid peroxidation-
induced DNA adduct. J Biol Chem 2004;279:17723-17730 
[96] Bartsch H, Nair J. Oxidative stress and lipid peroxidation-derived DNA-lesions in 
inflammation driven carcinogenesis. Cancer Detect Prev 2004;28:385-391 
[97] Speina E, Zielinska M, Barbin A, Gackowski D, Kowalewski J, Graziewicz MA, 
Siedlecki JA, Olinski R, Tudek B. Decreased repair activities of 1,N(6)-ethenoadenine and 
3,N(4)-ethenocytosine in lung adenocarcinoma patients. Cancer Res 2003;63:4351-4357 
[98] Gackowski D, Speina E, Zielinska M, Kowalewski J, Rozalski R, Siomek A, Paciorek T, 
Tudek B, Olinski R. Products of oxidative DNA damage and repair as possible biomarkers of 
susceptibility to lung cancer. Cancer Res 2003;63:4899-4902 
[99] Obtulowicz T, Winczura A, Speina E, Swoboda M, Janik J, Janowska B, Ciesla JM, 
Kowalczyk P, Jawien A, Gackowski D, Banaszkiewicz Z, Krasnodebski I, Chaber A, Olinski 
R, Nair J, Bartsch H, Douki T, Cadet J, Tudek B. Aberrant repair of etheno-DNA adducts in 
leukocytes and colon tissue of colon cancer patients. Free Radic Biol Med 2010;49:1064-
1071 
[100] Liu BQ, Wu YD, Li PH, Wei JX, Zhang T, Liu RL. Prostate cancer antigen-1 as a 
potential novel marker for prostate cancer. Asian J Androl 2007;9:821-826 
[101] Konishi N, Nakamura M, Ishida E, Shimada K, Mitsui E, Yoshikawa R, Yamamoto H, 
Tsujikawa K. High expression of a new marker PCA-1 in human prostate carcinoma. Clin 
Cancer Res 2005;11:5090-5097 
[102] Aravind L, Koonin EV. The DNA-repair protein AlkB, EGL-9, and leprecan define 
new families of 2-oxoglutarate- and iron-dependent dioxygenases. Genome Biol 
2001;2:RESEARCH0007 
Page 41 of 58
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
 
 39
[103] Delaney JC, Smeester L, Wong C, Frick LE, Taghizadeh K, Wishnok JS, Drennan CL, 
Samson LD, Essigmann JM. AlkB reverses etheno DNA lesions caused by lipid oxidation in 
vitro and in vivo. Nat Struct Mol Biol 2005;12:855-860 
[104] Mishina Y, Yang CG, He C. Direct repair of the exocyclic DNA adduct 1,N6-
ethenoadenine by the DNA repair AlkB proteins. J Am Chem Soc 2005;127:14594-14595 
[105] Maciejewska AM, Ruszel KP, Nieminuszczy J, Lewicka J, Sokolowska B, Grzesiuk E, 
Kusmierek JT. Chloroacetaldehyde-induced mutagenesis in Escherichia coli: the role of AlkB 
protein in repair of 3,N(4)-ethenocytosine and 3,N(4)-alpha-hydroxyethanocytosine. Mutat 
Res 684:24-34 
[106] Aas PA, Otterlei M, Falnes PO, Vagbo CB, Skorpen F, Akbari M, Sundheim O, Bjoras 
M, Slupphaug G, Seeberg E, Krokan HE. Human and bacterial oxidative demethylases repair 
alkylation damage in both RNA and DNA. Nature 2003;421:859-863 
[107] Begley TJ, Samson LD. AlkB mystery solved: oxidative demethylation of N1-
methyladenine and N3-methylcytosine adducts by a direct reversal mechanism. Trends 
Biochem Sci 2003;28:2-5 
[108] Falnes PO. Repair of 3-methylthymine and 1-methylguanine lesions by bacterial and 
human AlkB proteins. Nucleic Acids Res 2004;32:6260-6267 
[109] Koivisto P, Duncan T, Lindahl T, Sedgwick B. Minimal methylated substrate and 
extended substrate range of Escherichia coli AlkB protein, a 1-methyladenine-DNA 
dioxygenase. J Biol Chem 2003;278:44348-44354 
[110] Ougland R, Zhang CM, Liiv A, Johansen RF, Seeberg E, Hou YM, Remme J, Falnes 
PO. AlkB restores the biological function of mRNA and tRNA inactivated by chemical 
methylation. Mol Cell 2004;16:107-116 
[111] Kurowski MA, Bhagwat AS, Papaj G, Bujnicki JM. Phylogenomic identification of five 
new human homologs of the DNA repair enzyme AlkB. BMC Genomics 2003;4:48 
Page 42 of 58
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
 
 40
[112] Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, Hewitson KS, Yeo GS, 
McDonough MA, Cunliffe S, McNeill LA, Galvanovskis J, Rorsman P, Robins P, Prieur X, 
Coll AP, Ma M, Jovanovic Z, Farooqi IS, Sedgwick B, Barroso I, Lindahl T, Ponting CP, 
Ashcroft FM, O'Rahilly S, Schofield CJ. The obesity-associated FTO gene encodes a 2-
oxoglutarate-dependent nucleic acid demethylase. Science 2007;318:1469-1472 
[113] Yi C, Yang CG, He C. A non-heme iron-mediated chemical demethylation in DNA and 
RNA. Acc Chem Res 2009;42:519-529 
[114] Duncan T, Trewick SC, Koivisto P, Bates PA, Lindahl T, Sedgwick B. Reversal of 
DNA alkylation damage by two human dioxygenases. Proc Natl Acad Sci U S A 
2002;99:16660-16665 
[115] Falnes PO, Bjoras M, Aas PA, Sundheim O, Seeberg E. Substrate specificities of 
bacterial and human AlkB proteins. Nucleic Acids Res 2004;32:3456-3461 
[116] Mishina Y, Lee CH, He C. Interaction of human and bacterial AlkB proteins with DNA 
as probed through chemical cross-linking studies. Nucleic Acids Res 2004;32:1548-1554 
[117] Ringvoll J, Moen MN, Nordstrand LM, Meira LB, Pang B, Bekkelund A, Dedon PC, 
Bjelland S, Samson LD, Falnes PO, Klungland A. AlkB homologue 2-mediated repair of 
ethenoadenine lesions in mammalian DNA. Cancer Res 2008;68:4142-4149 
[118] Fu D, Samson LD. Direct repair of 3,N(4)-ethenocytosine by the human ALKBH2 
dioxygenase is blocked by the AAG/MPG glycosylase. DNA Repair (Amst)  
[119] Gilljam KM, Feyzi E, Aas PA, Sousa MM, Muller R, Vagbo CB, Catterall TC, Liabakk 
NB, Slupphaug G, Drablos F, Krokan HE, Otterlei M. Identification of a novel, widespread, 
and functionally important PCNA-binding motif. J Cell Biol 2009;186:645-654 
[120] Ringvoll J, Nordstrand LM, Vagbo CB, Talstad V, Reite K, Aas PA, Lauritzen KH, 
Liabakk NB, Bjork A, Doughty RW, Falnes PO, Krokan HE, Klungland A. Repair deficient 
Page 43 of 58
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
 
 41
mice reveal mABH2 as the primary oxidative demethylase for repairing 1meA and 3meC 
lesions in DNA. Embo J 2006;25:2189-2198 
[121] Westbye MP, Feyzi E, Aas PA, Vagbo CB, Talstad VA, Kavli B, Hagen L, Sundheim 
O, Akbari M, Liabakk NB, Slupphaug G, Otterlei M, Krokan HE. Human AlkB homolog 1 is 
a mitochondrial protein that demethylates 3-methylcytosine in DNA and RNA. J Biol Chem 
2008;283:25046-25056 
[122] Muller TA, Meek K, Hausinger RP. Human AlkB homologue 1 (ABH1) exhibits DNA 
lyase activity at abasic sites. DNA Repair (Amst) 9:58-65 
[123] Jia G, Yang CG, Yang S, Jian X, Yi C, Zhou Z, He C. Oxidative demethylation of 3-
methylthymine and 3-methyluracil in single-stranded DNA and RNA by mouse and human 
FTO. FEBS Lett 2008;582:3313-3319 
[124] Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, Yi C, Lindahl T, Pan T, Yang YG, He 
C. N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. 
Nat Chem Biol 2011;7:885-887 
[125] Songe-Moller L, van den Born E, Leihne V, Vagbo CB, Kristoffersen T, Krokan HE, 
Kirpekar F, Falnes PO, Klungland A. Mammalian ALKBH8 possesses tRNA 
methyltransferase activity required for the biogenesis of multiple wobble uridine 
modifications implicated in translational decoding. Mol Cell Biol 30:1814-1827 
[126] Begley U, Dyavaiah M, Patil A, Rooney JP, DiRenzo D, Young CM, Conklin DS, 
Zitomer RS, Begley TJ. Trm9-catalyzed tRNA modifications link translation to the DNA 
damage response. Mol Cell 2007;28:860-870 
[127] Leihne V, Kirpekar F, Vagbo CB, van den Born E, Krokan HE, Grini PE, Meza TJ, 
Falnes PO. Roles of Trm9- and ALKBH8-like proteins in the formation of modified wobble 
uridines in Arabidopsis tRNA. Nucleic Acids Res 39:7688-7701 
Page 44 of 58
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
 
 42
[128] Pan Z, Sikandar S, Witherspoon M, Dizon D, Nguyen T, Benirschke K, Wiley C, Vrana 
P, Lipkin SM. Impaired placental trophoblast lineage differentiation in Alkbh1(-/-) mice. Dev 
Dyn 2008;237:316-327 
[129] Shimada K, Nakamura M, Ishida E, Higuchi T, Yamamoto H, Tsujikawa K, Konishi N. 
Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 
in human prostate cancer. Cancer Sci 2008;99:39-45 
[130] Tsujikawa K, Koike K, Kitae K, Shinkawa A, Arima H, Suzuki T, Tsuchiya M, Makino 
Y, Furukawa T, Konishi N, Yamamoto H. Expression and sub-cellular localization of human 
ABH family molecules. J Cell Mol Med 2007;11:1105-1116 
[131] Hu W, Feng Z, Eveleigh J, Iyer G, Pan J, Amin S, Chung FL, Tang MS. The major lipid 
peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 
249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma. 
Carcinogenesis 2002;23:1781-1789 
[132] Feng Z, Hu W, Amin S, Tang MS. Mutational spectrum and genotoxicity of the major 
lipid peroxidation product, trans-4-hydroxy-2-nonenal, induced DNA adducts in nucleotide 
excision repair-proficient and -deficient human cells. Biochemistry 2003;42:7848-7854 
[133] Esterbauer H, Eckl P, Ortner A. Possible mutagens derived from lipids and lipid 
precursors. Mutat Res 1990;238:223-233 
[134] Eckl PM, Ortner A, Esterbauer H. Genotoxic properties of 4-hydroxyalkenals and 
analogous aldehydes. Mutat Res 1993;290:183-192 
[135] Karlhuber GM, Bauer HC, Eckl PM. Cytotoxic and genotoxic effects of 4-
hydroxynonenal in cerebral endothelial cells. Mutat Res 1997;381:209-216 
[136] Huang H, Wang H, Kozekova A, Rizzo CJ, Stone MP. Formation of a N2-dG:N2-dG 
carbinolamine DNA cross-link by the trans-4-hydroxynonenal-derived (6S,8R,11S) 1,N2-dG 
adduct. J Am Chem Soc 133:16101-16110 
Page 45 of 58
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
 
 43
[137] Maddukuri L, Speina E, Christiansen M, Dudzinska D, Zaim J, Obtulowicz T, 
Kabaczyk S, Komisarski M, Bukowy Z, Szczegielniak J, Wojcik A, Kusmierek JT, Stevnsner 
T, Bohr VA, Tudek B. Cockayne syndrome group B protein is engaged in processing of DNA 
adducts of lipid peroxidation product trans-4-hydroxy-2-nonenal. Mutat Res 2009;666:23-31 
[138] Tornaletti S. Transcription arrest at DNA damage sites. Mutat Res 2005;577:131-145 
[139] Licht CL, Stevnsner T, Bohr VA. Cockayne syndrome group B cellular and 
biochemical functions. Am J Hum Genet 2003;73:1217-1239 
[140] Zarkovic K. 4-hydroxynonenal and neurodegenerative diseases. Mol Aspects Med 
2003;24:293-303 
[141] Hayashi M, Itoh M, Araki S, Kumada S, Shioda K, Tamagawa K, Mizutani T, 
Morimatsu Y, Minagawa M, Oda M. Oxidative stress and disturbed glutamate transport in 
hereditary nucleotide repair disorders. J Neuropathol Exp Neurol 2001;60:350-356 
[142] Feng Z, Hu W, Tang MS. Trans-4-hydroxy-2-nonenal inhibits nucleotide excision 
repair in human cells: a possible mechanism for lipid peroxidation-induced carcinogenesis. 
Proc Natl Acad Sci U S A 2004;101:8598-8602 
[143] Kumar S, Kokate RA, Sahu M, Chaudhary P, Sharma R, Awasthi S, Awasthi YC. 
Inhibition of mercapturic acid pathway-mediated disposal of 4-hydroxynonenal causes 
complete and sustained remission of human cancer xenografts in nude mice. Indian J Exp Biol 
49:817-825 
[144] Pizzimenti S, Menegatti E, Berardi D, Toaldo C, Pettazzoni P, Minelli R, Giglioni B, 
Cerbone A, Dianzani MU, Ferretti C, Barrera G. 4-hydroxynonenal, a lipid peroxidation 
product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon 
carcinoma cell lines through the inhibition of telomerase activity. J Nutr Biochem 
2010;21:818-826 
Page 46 of 58
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
 
 44
[145] Pizzimenti S, Briatore F, Laurora S, Toaldo C, Maggio M, De Grandi M, Meaglia L, 
Menegatti E, Giglioni B, Dianzani MU, Barrera G. 4-Hydroxynonenal inhibits telomerase 
activity and hTERT expression in human leukemic cell lines. Free Radic Biol Med 
2006;40:1578-1591 
[146] Schmid K, Nair J, Winde G, Velic I, Bartsch H. Increased levels of promutagenic 
etheno-DNA adducts in colonic polyps of FAP patients. Int J Cancer 2000;87:1-4 
[147] Nair J, Gansauge F, Beger H, Dolara P, Winde G, Bartsch H. Increased etheno-DNA 
adducts in affected tissues of patients suffering from Crohn's disease, ulcerative colitis, and 
chronic pancreatitis. Antioxid Redox Signal 2006;8:1003-1010 
 
 
Page 47 of 58
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
 
 45
Table 1. DNA ethenoadducts levels in various human diseases.  
Disease Affected 
organ 
Absolute values of 
ethenoadducts per 109 
parent nucleotides  
Fold increase of 
DNA 
ethenoadducts 
Reference 
Wilson’s disease Liver εA - 61.03 ± 7.95 
εC - 91.50 ±  36.02 
3 εA, 3 εC  
in comparison to 
normal liver  
[71] 
Primary 
hemochromatosis 
Liver εA - 46.62 ±  32.83 
εC - 64.32 ±  11.55 
2 εA, 2 εC  
in comparison to 
normal liver 
[71] 
Familial adenomatous 
polyposis 
Colon 
polyps 
εA - 65.3 
εC - 31.4 
2 εA, 2 εC  
in comparison to 
unaffected colon 
[146] 
Crohn’s disease Colon εC - 325 ±  346 20 εC  
in comparison to 
asymptomatic 
colon 
[147] 
Ulcerative colitis Colon εC - 69 ±  36 4 εC  
in comparison to 
asymptomatic 
colon 
[147] 
Chronic pancreatitis Pancreas εA - 63 ±  56 
εC - 354 ±  251 
3 εA, 28 εC 
in comparison to 
normal pancreas 
[147] 
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Figure 1. Pathways of lipid peroxidation. 
Figure 2. Structures of LPO-derived reactive aldehydes (according to [7]). Left panel- 
general structures, right panel- examples of reactive aldehydes that belong to particular 
families, HHE- 4-hydroxy-2-hexenal, HNE- 4-hydroxy-2-nonenal, MDA- malondialdehyde, 
ONE- 4-oxo-2-nonenal. 
Figure 3. Mechanisms of HNE formation (according to [17]). A- from 9-hydroxyperoxy-
octadecenoic acid (9(S)-HPODE) as a precursor; B- from 13-hydroxyperoxy-octadecenoic 
acid (13(S)-HPODE) as a precursor.  
Figure 4. Michael addition of thiols (according to [10]). 
Figure 5. Schiff-base formation with primary amines (according to [10]). 
Figure 6. The major exocyclic DNA adducts. M1dG, 1,N2-ethenoguanine (1,N2-εG), N2,3-
ethenoguanine (N2,3εG), 3,N4-ethenocytosine (εC), 1,N6-ethenoadenine (εA). 
Figure 7. Interaction of HNE with deoxyguanosine. 
Figure 8. Interaction of HNE epoxide with deoxyguanosine. 
Figure 9. AlkB mechanism of direct reversal. 
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Figure 1. Pathways of lipid peroxidation  
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Figure 2. Structures of LPO-derived reactive aldehydes (according to [7]). Left panel- general structures, 
right panel- examples of reactiv  aldehydes that belong to particular families, HHE- 4-hydroxy-2-hexenal, 
HNE- 4-hydroxy-2-nonenal, MDA- malondialdehyde, ONE- 4-oxo-2-nonenal  
59x24mm (300 x 300 DPI)  
 
 
Page 51 of 58
http://mc.manuscriptcentral.com/gfrr
Free Radical Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer-Review Only
  
 
 
Figure 3. Mechanisms of HNE formation (according to [11]). A- from 9-hydroxyperoxy-octadecenoic acid 
(9(S)-HPODE) as a precursor; B- from 13-hydroxyperoxy-octadecenoic acid (13(S)-HPODE) as a precursor.  
117x93mm (300 x 300 DPI)  
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Figure 4. Michael addition of HNE to thiols (according to [10])  
23x4mm (300 x 300 DPI)  
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Figure 5. Schiff-base formation with primary amines (according to [10])  
132x11mm (300 x 300 DPI)  
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Figure 6. Major modifications of DNA bases by LPO products. M1dG, 1,N2-ethenoguanine (1,N2-εG), N2,3-
ethenoguanine (N2,3-εG), 3, N4-ethenocytosine (εC), 1,N6-ethenoadenine (εA)  
99x73mm (300 x 300 DPI)  
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Figure 7. Interaction of HNE with deoxyguanosine  
123x133mm (300 x 300 DPI)  
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Figure 8. Interaction of HNE epoxide with deoxyguanosine  
173x227mm (300 x 300 DPI)  
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Figure 9. The mechanism of oxidative dealkylation of DNA bases by AlkB proteins  
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